Journal of Cardiac Failure
Volume 13, Issue 5 , Pages 360-364 , June 2007

Prognostic Value of Blood Urea Nitrogen in Patients Hospitalized With Worsening Heart Failure: Insights From the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) Study

  • Gerasimos Filippatos, MD

      Affiliations

    • From the Department of Cardiology, Athens University, Athens, Greece
    • ,
  • Joseph Rossi, MD

      Affiliations

    • Division of Cardiology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois
    • ,
  • Donald M. Lloyd-Jones, MD, ScM

      Affiliations

    • Division of Cardiology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois
    • ,
  • Wendy Gattis Stough, PharmD

      Affiliations

    • Division of Cardiology, Duke University Medical Center, Durham, North Carolina
    • Campbell University School of Pharmacy Department of Clinical Research, Research Triangle Park, North Carolina
    • ,
  • John Ouyang, PhD

      Affiliations

    • Otsuka Maryland Research Institute, Rockville, Maryland
    • ,
  • David D. Shin

      Affiliations

    • Division of Cardiology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois
    • ,
  • Christopher O'Connor, MD

      Affiliations

    • Division of Cardiology, Duke University Medical Center, Durham, North Carolina
    • ,
  • Kirkwood F. Adams, MD

      Affiliations

    • Division of Cardiology, University of North Carolina, Chapel Hill, North Carolina
    • ,
  • Cesare Orlandi, MD

      Affiliations

    • Otsuka Maryland Research Institute, Rockville, Maryland
    • ,
  • Mihai Gheorghiade, MD

      Affiliations

    • Division of Cardiology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois
    • Corresponding Author InformationReprint requests: Mihai Gheorghiade, MD, Division of Cardiology, Northwestern University, Feinberg School of Medicine, Galter 10-240, 201 E Huron Street, Chicago, IL 60611.

Received 30 June 2006 ,Revised 12 January 2007 ,Accepted 21 February 2007.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 The ACTIV in CHF trial and this analysis were funded by Otsuka Maryland Research Institute, Rockville, Maryland.

PII: S1071-9164(07)00051-6

doi: 10.1016/j.cardfail.2007.02.005

Journal of Cardiac Failure
Volume 13, Issue 5 , Pages 360-364 , June 2007

Article Tools

* Image Usage & Resolution